AI Terminal
ESKEN LIMITED
Director's Dealing • Jun 16, 2022
5145_dirs_2022-06-16_52eed599-7848-4c3d-be33-7ee1d5f5a2e5.html
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 1868P
Esken Limited
16 June 2022
17 June 2022
Esken Limited
("Esken" or the "Company")
Director/PDMR Shareholdings
Esken, the aviation and renewable energy group, announces that Nick Dilworth, who is a Director, and Charlotte Dilworth, a person closely associated with Mr Dilworth, have sold a total of 153 Ordinary Shares (at a price per share of £0.1023 for 97 shares and £0.1031 for 56 shares)) held in the name of a nominee account on their behalf to meet certain charges associated with that account. The number of shares held by Mr and Mrs Dilworth following the sale is 220,396 Ordinary Shares.
| Esken Limited | ||
| Charlie Geller, Communications Director | C/O Tulchan Communications | |
| Tulchan Communications | +44 207 353 4200 | |
| Olivia Peters / David Allchurch | [email protected] |
Notification and public disclosure of transactions by persons discharging managerial responsibilities and person closely associated with them
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Nick Dilworth
2
Reason for the notification
a)
Position/status
Director
b)
Initial notification
/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Esken Limited
b)
LEI
213800BINQVRZFKA3E89
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 10 pence each in Esken Limited
ISIN: GB00B03HDJ73
b)
Nature of the transaction
Sale of Ordinary Shares in Esken Limited to cover broker administrative charges
c)
Price(s) and
volume(s)
Shares sold by nominee at £0.1023 per share
97
d)
Aggregated information
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| £0.1023 | 97 |
e)
Date of the transaction
16 June 2022
| f) | Place of the transaction | London Stock Exchange (XLON) |
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Charlotte Dilworth
2
Reason for the notification
a)
Position/status
Person closely associated with Director
b)
Initial notification
/Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Esken Limited
b)
LEI
213800BINQVRZFKA3E89
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 10 pence each in Esken Limited
ISIN: GB00B03HDJ73
b)
Nature of the transaction
Sale of Ordinary Shares in Esken Limited to cover broker administrative charges
c)
Price(s) and
volume(s)
Shares sold by nominee at £0.1031 per share
56
d)
Aggregated information
- Aggregated volume
- Price
| Price(s) | Volume(s) |
| £0.1031 | 56 |
e)
Date of the transaction
14 June 2022
f)
Place of the transaction
London Stock Exchange (XLON)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHEADKKFASAEFA